title: Should anaesthetists be giving dexamethasone to patients with malignancy?
authors.affiliation: Department of Anaesthetics, Wipps Cross University Hospital, London E11 1NR, UK.
authors.forename: Jessica
authors.initials: J
authors.lastname: Hoyle
authors.forename: Andrew
authors.initials: A
authors.lastname: Williams
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000932:Antiemetics / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003907:Dexamethasone / Q000008:administration & dosage*; D004487:Edema / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D000932:Antiemetics; D000970:Antineoplastic Agents; D003907:Dexamethasone